Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Hospital-Treated Gram-Positive Infections – Epidemiology – Middle East & Africa Data
Clarivate Epidemiology’s coverage of hospital treated (HT) gram-positive infections (GPIs) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the…
Methicillin-Resistant Staphylococcus Aureus Infections (MRSA) | Disease Landscape and Forecast | G7 | 2016
Methicillin-resistant Staphylococcus aureus (MRSA) is a clinically important gram-positive pathogen found in both the hospital and outpatient settings. The newly marketed oritavancin (The Medicine…
Hospital-Treated Gram-Negative Infections | Access and Reimbursement | US | 2016
Gram-Negative Infections | Access & Reimbursement | US examines the market access factors that influence commercial success of therapies for the treatment of gram-negative infections. The analysis…
Gram-Negative Infections | Unmet Need | HABP/VABP Gram-Negative Infections | US/EU | 2016
Hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) are serious hospital-treated infections associated with high rates of multi-drug resistant (MDR) bacteria, including…
